Penserra Capital Management LLC Mersana Therapeutics, Inc. Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$5.48 - $9.86 $8,987 - $16,170	-1,640 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$8.56 - $14.47 $470 - $795	55 Added 3.47%	1,640 $15,000
Q2 2021 Aug 12, 2021	BUY	$13.28 - $18.07 $265 - $361	20 Added 1.28%	1,585 $21,000
Q1 2021 May 13, 2021	SELL	$15.31 - $26.52 $76 - $132	-5 Reduced 0.32%	1,565 $25,000
Q4 2020 Feb 12, 2021	BUY	$16.84 - $27.59 $26,438 - $43,316	1,570 New	1,570 $41,000

121

116M

233K

457K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $198M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.